Skip to main content

Search this site

Eyebrow Menu

Magazine
Photo Galleries
Podcasts
Comparison Charts
Blogs
- Blogs
- Blog Series
Calendar
360 Photos
Case Studies
Buyer's Guide

Search this site

Sign In
New User? Register Here

FDA
COVID-19
Imaging
3-D Printing

Angiography

Computed Tomography (CT)

Contrast media/injectors

Digital Radiography (DR)

Magnetic Resonance Imaging (MRI)

Molecular Imaging

Pediatric Imaging

Radiation dose management

Radiographic Fluoroscopy (RF)

Ultrasound Imaging
Information Technology
Advanced visualization

Analytics Software

Archive/storage

Artificial Intelligence

Clinical decision support

Digital Pathology

Enterprise Imaging

Flat panel displays

Imaging software development

PACS

Population Health

Remote viewing systems

Teleradiology

Vendor neutral archives (VNA)
Women's Health
Breast Biopsy Systems

Breast Density

Breast Imaging

Breast MRI

Ultrasound Women's Health
Radiation Oncology
Oncology information management systems (OIMS)

Patient positioning/immobilization

Proton Therapy

Radiation therapy

Treatment planning software/systems
Video
Webinars
Conference Coverage
AAPM

ACC

ACR

AHRA

AIMed

ARRS

ASTRO

ECR

HIMSS

RSNA

SBI

SCCT

SIIM

SIR

SNMMI

If you enjoy this content, please share it with a colleague

If you enjoy this content, please share it with a colleague

Double-Crane Pharmaceutical Company

China

RELATED CONTENT

Lantheus Announces Partnership for Distribution of Definity Echo Contrast in China

News

Lantheus Announces Partnership for Distribution of Definity Echo ...

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.

February 29, 2012

© Copyright Wainscot Media. All Rights Reserved.

Bottom Menu

Topics We Cover
Glossary
Advertise
Contact
Privacy Policy
Cookie Policy
Terms and Conditions

Subscribe Now

E-newsletter Subscription form